US Patent 9062115 Therapeutic factor VIII antibodies
Patent 9062115 was granted and assigned to Novo Nordisk on June, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9062115 Therapeutic factor VIII antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.